Pacific NorthwestPop. 7.8M

GLP-1 Coverage & Costs in Washington (2026)

$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Washington at intake.

The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.

Medicaid: not covered as of January 2026 (KFF)
Eduard Cristea
Eduard Cristea
Published: |Updated:

Washington Medicaid Coverage for GLP-1

Medicaid: not covered as of January 2026 (KFF)

KFF's map lists Washington as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.

Your Options in Washington:

  • Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Washington
  • Commercial or employer insurance: check your plan's drug list and prior authorization rules
  • Medicare GLP-1 Bridge for eligible Part D enrollees (see below)

Washington Medicaid GLP-1 Prescriptions in 2025

Prescriptions paid

111,160

Rank of 51

#23

Medicaid paid, before rebates

$79.7 million

Most-filled product

Liraglutide (generic)

Washington Medicaid paid for 111,160 GLP-1 prescriptions in 2025, 1% of the 11.26 million paid nationally and number 23 of 51 (50 states and DC). It reimbursed pharmacies $79.7 million before manufacturer rebates, about $717 per prescription, and the most-filled product was Liraglutide (generic). These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 3,462 of those prescriptions (3.1%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.

From 2021 to 2025, Washington Medicaid GLP-1 prescriptions went from 51,557 to 111,160, 2.2 times the 2021 count. From 2024 to 2025 the count rose by 8,252.

2021

51,557

2022

68,864

2023

95,705

2024

102,908

2025

111,160

ProductWA Medicaid prescriptions, 2025Share
Liraglutide (generic)47,67342.9%
Ozempic28,32025.5%
Mounjaro21,68219.5%
Trulicity3,7793.4%
Bydureon3,4313.1%
Zepbound2,2472%
Rybelsus1,6291.5%
Wegovy1,2151.1%
Victoza8790.8%
Byetta2280.2%
Exenatide (generic)770.1%

Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.

Washington Employee Plan and Insurer GLP-1 Rules

Washington Public Employees Benefits Board (PEBB) program

Does not cover GLP-1s for weight loss

No Washington PEBB plan covers GLP-1 drugs for weight loss, as of the Health Care Authority's February 2026 newsletter.

  • The Health Care Authority's February 2026 PEBB newsletter says no PEBB plan covers this drug class for weight loss.

    “This class of drugs is not currently covered for weight loss by any PEBB plans.”

    Source: Washington State Health Care Authority. Read October 29, 2026.

Premera Blue Cross

Covers with limits

Premera Blue Cross covers weight-management GLP-1s only when an employer group elects that benefit. In 2026 it added GLP-1 Access Select, an employer option that sets a BMI threshold of 35 for weight-loss GLP-1s.

  • Premera's February 19, 2026 employer update says weight-management GLP-1s are covered only when the employer elects the benefit.

    “Weight management GLP-1s are reviewed under the weight-loss drug policy and are only covered when an employer group elects this benefit.”

    Source: Premera Blue Cross. Read October 29, 2026.

  • Its June 2026 employer update describes GLP-1 Access Select, which sets a BMI threshold of 35.

    “It sets a BMI threshold of 35 for weight loss GLP‑1s.”

    Source: Premera Blue Cross. Read October 29, 2026.

Comparing self-pay programs in Washington?

2-minute quiz: filter by budget and medication preference.

Take the quiz →

Telehealth Programs to Check for Washington

We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Washington. The rest record a state count without naming the states, so confirm Washington with the program at intake before you pay.

What Programs' Own Pages Say About Washington

8 of the 8 programs whose own pages name the states they serve include Washington: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.

Trimi's state table lists Washington as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for Washington is RCW 18.134.030(3) (Uniform Telehealth Act, 2024 c 212). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.

Programs on Our List, in Published Order

Compounded GLP-1 care with one-month and prepaid plans

Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support

Affordable compounded semaglutide from $119/mo with free shipping and health coaching

From $119/mo semaglutide, from $185/mo tirzepatide, 12-month planCompounded Semaglutide, Compounded TirzepatideAll 50 States

Personalized GLP-1 weight loss with licensed providers and nationwide coverage

45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.

Estimated GLP-1 Costs in Washington

Best Value

Telehealth (Compounded)

$79 to $399/mo

Recorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.

Wegovy

Brand prices with and without insurance.

Zepbound

List, LillyDirect and savings card prices.

No insurance

Self-pay GLP-1 options without coverage.

The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.

Medicare Part D GLP-1 Claims in Washington, 2024

Washington prescribers wrote 336,462 Medicare Part D GLP-1 claims in 2024, number 24 of 51, with $426.8 million in gross drug cost before rebates. Ozempic led with 170,630 claims for 33,653 enrollees. Wegovy had 3,434 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.

ProductWA Part D claimsEnrollees
Ozempic170,63033,653
Trulicity67,37113,018
Mounjaro57,34110,799
Rybelsus19,3584,900
Victoza9,190Not given
Bydureon Bcise6,0251,330
Wegovy3,434852
Liraglutide2,589935
Byetta524162

Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.

Now Live — Launched July 1, 2026

Medicare GLP-1 Bridge Program in Washington

The Bridge is national, so the rules are the same in Washington as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.

Patient Cost

$50/mo

Launch Date

July 1, 2026

Runs Through

Dec 31, 2027

Read the Full Medicare Guide

How Washington Compares to Other Pacific Northwest States

Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Washington and its neighbors in the Pacific Northwest are recorded:

StateMedicaid and GLP-1s for obesityMedicaid GLP-1 Rx, 2025
Washington (this page)Not covered111,160
OregonNot covered72,779

Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.

KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.

GLP-1 Guides for Washington Cities

If Your Insurance Denies GLP-1 Coverage in Washington

Commercial plans offer an internal appeal, then external review; Washington Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.

How to Check Your Specific Plan in Washington

  • Washington Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
  • State employees: Washington Public Employees Benefits Board (PEBB) program, does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
  • Insurers on record for Washington: Premera Blue Cross. Each still depends on whether your employer bought the weight-loss benefit.
  • Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.

Find the Right GLP-1 Provider in Washington

Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Washington.

Frequently Asked Questions — Washington

Does Washington Medicaid cover GLP-1 medications for weight loss?
KFF's map lists Washington as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan. You can also look at telehealth programs (recorded monthly-plan prices from $79/month; confirm Washington at intake), commercial insurance, or the Medicare GLP-1 Bridge.
How many GLP-1 prescriptions did Washington Medicaid pay for in 2025?
Washington Medicaid paid for 111,160 GLP-1 prescriptions in 2025, 1% of the 11.26 million paid nationally and number 23 of 51 (50 states and DC). It reimbursed pharmacies $79.7 million before manufacturer rebates, about $717 per prescription, and the most-filled product was Liraglutide (generic). These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 3,462 of those prescriptions (3.1%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it. From 2021 to 2025, Washington Medicaid GLP-1 prescriptions went from 51,557 to 111,160, 2.2 times the 2021 count. From 2024 to 2025 the count rose by 8,252. Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026).
How many Medicare Part D GLP-1 claims were there in Washington in 2024?
Washington prescribers wrote 336,462 Medicare Part D GLP-1 claims in 2024, number 24 of 51, with $426.8 million in gross drug cost before rebates. Ozempic led with 170,630 claims for 33,653 enrollees. Wegovy had 3,434 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses. Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026).
Does the Washington state employee health plan cover GLP-1s for weight loss?
Washington Public Employees Benefits Board (PEBB) program: does not cover glp-1s for weight loss. No Washington PEBB plan covers GLP-1 drugs for weight loss, as of the Health Care Authority's February 2026 newsletter. Source: Washington State Health Care Authority, read October 29, 2026.
What is the cheapest way to get GLP-1 medication in Washington?
The lowest monthly-plan price we have recorded among programs on this page is $79/month (Embody, compounded semaglutide, monthly plan). Embody lists 48 states and our records do not name them, so confirm Washington at intake. Medicare Part D enrollees who qualify can get Foundayo, Wegovy or Zepbound KwikPen for $50/month through the Bridge.
Which online GLP-1 programs serve Washington?
8 of the 8 programs whose own pages name the states they serve include Washington: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. For the other programs on this page, confirm Washington at intake before you pay.
Does Medicare cover GLP-1s in Washington?
Yes for eligible Part D enrollees in Washington: $50/month through the Medicare GLP-1 Bridge, July 1, 2026 to December 31, 2027, under the BMI rules in the Medicare section above.

Ready to start?

Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody